Bisphenol A in renal insufficiency: how long will it be used? Is it time to avoid it? Emilio González-Parra; Rafael Moreno-Gómez-Toledano; Sebastián Mas-Fontao; Ricardo J. Bosch;

Predictors of outcome in a Spanish cohort of patients with Fabry disease on enzyme replacement therapy Marian Goicoechea; Francisco Gomez-Preciado; Silvia Benito; Joan Torras; Roser Torra; Ana Huerta; Alejandra Restrepo; Jessica Ugalde; Daniela Estefania Astudillo; Irene Agraz; Manuel Lopez-Mendoza; Gabriel de Arriba; Elena Corchete; Borja Quiroga; Maria Jose Gutierrez; Maria Luisa Martin-Conde; Vanessa Lopes; Carmela Ramos; Irene Mendez; Mercedes Cao; Fernando Dominguez; Alberto Ortiz;

Recommendations for the evaluation and treatment of patients with diabetes and albuminuria. Role of non-steroidal mineralocorticoid antagonism Juan Payán López; Pedro Chinchurreta Capote; Antonio Hormigo Pozo; Luis Castilla-Guerra; José Carlos Fernández-García; Rosa Fernández Olmo; María José Espigares Huete;